Current Treatment for Low-Risk Prostate Cancer in China: A National Network Survey
Yongbao Wei(Second Xiangya Hospital of Central South University), Xiande Cao(Affiliated Hospital of Jining Medical University), Peng Zhang(Wuhan University), Shaoxiong Ming(Changhai Hospital), Dewen Zhong(First Affiliated Hospital of Fujian Medical University), Daozhang Yuan(Guangzhou Medical University), Yanlin Wen(Nanchong Central Hospital), Xin Li(Hubei University of Medicine), Wei Song(Qingdao University), Longfei Liu(Second Xiangya Hospital of Central South University)
Cited by 11
Related Papers
Metformin targets c-MYC oncogene to prevent prostate cancer
|Carcinogenesis|2013|141
LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β-catenin signaling pathway
|Oncology Reports|2014|137
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways
|Nature Communications|2018|120
MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer
|Scientific Reports|2014|108